In addition, CD123 co-segregates with FLT3-internal tandem duplication (ITD) mutation-positive CD34+CD38— cells suggesting that CD123 is a robust LSC marker in FLT3-ITD-mutated AML (38). The gene discussed is CD38; the disease is acute myeloid leukemia.